Location History:
- München, DE (2014 - 2017)
- Munich, DE (2018 - 2020)
Company Filing History:
Years Active: 2014-2020
Title: Spotlight on Inventor Johannes-Peter Geiger
Introduction
Johannes-Peter Geiger, based in Munich, Germany, is a prominent inventor known for his significant contributions to the field of biochemistry and pharmacology. With a total of four patents under his name, Geiger continues to push the boundaries of scientific innovation, particularly in the development of novel agents for medical applications.
Latest Patents
Among Geiger's most recent innovations are two patents titled "Conjugate with target-finding ligand and use thereof." These patents describe a unique conjugate that comprises an agent complex encapsulated by an encapsulation material along with a target-finding ligand, specifically a prostacyclin analog. This inventive approach highlights the potential for enhanced therapeutic applications by utilizing targeting mechanisms that aim to improve the specificity and efficacy of medical treatments.
Career Highlights
Geiger is currently associated with Ethris GmbH, where he collaborates with a team of researchers and professionals dedicated to advancing therapeutic technologies. His work is characterized by a commitment to innovation and a desire to integrate cutting-edge science into real-world medical solutions. The patents he has authored reflect a trajectory of continuous improvement and responsiveness to the needs within the healthcare sector.
Collaborations
In his professional journey, Geiger collaborates closely with Carsten Rudolph, leveraging their combined expertise to drive forward research initiatives. This partnership fosters an environment of creativity and innovation, aimed at developing groundbreaking solutions that address complex medical challenges.
Conclusion
Johannes-Peter Geiger exemplifies the spirit of innovation in the realm of biochemistry, with his contributions solidifying his reputation as a forward-thinking inventor. His patents, particularly those focusing on target-finding ligands and agent complexes, pave the way for increased efficiency in medical treatments, demonstrating the essential role of inventors in shaping the future of healthcare. As Geiger continues his work at Ethris GmbH, the potential for further advancements remains promising, ensuring his name will be recognized in the annals of scientific innovation.